Niagen Bioscience, Inc. (NAGE)
Medicinal Chemicals & Botanical Products
Latest Price
$3.00
TTM P/E
16.67
Normalized P/E
--
Div Yield
--
Book Value
1.04
P/B Ratio
2.89
Valuation metrics
adjust assumptions →EPS: $0.20
Book value / share: $0.96
Formula: √(22.5 × EPS × BVPS)
Graham Number
$2.08
31% downside
EPS: $0.20
Target P/E: 17×
Formula: EPS × P/E
P/E Fair Value
$3.40
+13% upside
Institutional Ownership
40.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4.18M | $13.0M | 5.30% | +313.0K | 2026-06-30 |
| SteelPeak Wealth, LLC | 3.50M | $11.0M | 4.44% | +127.1K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.15M | $6.0M | 2.72% | -2.3K | 2026-06-30 |
| Tieton Capital Management, LLC | 2.01M | $6.0M | 2.55% | -20.7K | 2026-06-30 |
| Qube Research & Technologies Ltd | 1.63M | $5.0M | 2.06% | -89.6K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.48M | $4.0M | 1.87% | +133.7K | 2026-06-30 |
| UBS Group AG | 1.28M | $4.0M | 1.63% | -122.2K | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 1.26M | $4.0M | 1.60% | +10.8K | 2026-06-30 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.17M | $3.0M | 1.48% | -1.21M | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.17M | $3.0M | 1.48% | -55.3K | 2026-06-30 |